Search

Atrion Corp

Suletud

459.88 0.05

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

459.88

Max

459.88

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

4. nov 2024

Järgmine dividendimakse kuupäev

27. sept 2024

Järgmine aktsia dividendi kuupäev (ex-date)

12. sept 2024

Atrion Corp Graafik

Atrion Corp Prognoos

Ettevõttest Atrion Corp

Atrion Corporation (Atrion) is engaged in developing and manufacturing products primarily for medical applications. The Company markets components to other equipment manufacturers for incorporation in their products and sell finished devices to physicians, hospitals, clinics and other treatment centers. Its medical products primarily serve the fluid delivery, cardiovascular and ophthalmology markets. Its fluid delivery products include valves designed to fill, hold and release controlled amounts of fluids or gasses in fields, such as anesthesia and oncology. Its cardiovascular product, Myocardial Protection System (MPS3), is a technology used in the open-heart surgery that delivers fluids and medications, mixes critical drugs, and controls temperature and pressure. Its ophthalmic products include specialized medical devices that disinfect contact lenses. Atrion also manufacture a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.